Ten Years 
Closer to Prevention

 Celebrating a decade of accelerated progress for Alzheimer’s research.

Watch the Film

Cardinal Gala

Join Us as We Celebrate 
Ten Years of Groundbreaking Research and Prevention

Mark your calendar for June 14 and celebrate a decade of trailblazing work at the Alzheimer’s Therapeutic Research Institute with an unforgettable night of fine dining, live music, and joyful celebration. This special gala honors ATRI’s 10-year journey while raising vital funds to advance Alzheimer’s awareness, treatments, research, and prevention.
Reserve Your Tickets

Take Action

Invest in a Future Without Alzheimer’s

Be part of the change. The fight against Alzheimer’s Disease is a shared effort. Support groundbreaking Alzheimer’s research by becoming a sponsor and donating today.
Become a SponsorDonate Now
Be part of the change. The fight against Alzheimer’s Disease is a shared effort. Support groundbreaking Alzheimer’s research by becoming a sponsor and donating today.

Art Competition

Join Dame Zandra Rhodes in Making Alzheimer’s Visible

Be part of the movement that blends art and science to spark change. ATRI invites all designers and artists to participate in the “Make Alzheimer’s Visible” art project. Dame Zandra Rhodes challenges you to create a visionary design that highlights the progress in Alzheimer’s research—from current treatments to the hope for prevention within the next decade.

Selected works will be showcased in the “Make Alzheimer’s Visible” exhibition, inspiring engagement and advancing the mission to fight Alzheimer’s. Additionally, Dame Zandra Rhodes herself will create a special piece of artwork to be auctioned at the Cardinal Gala, with proceeds supporting Alzheimer’s research.

Learn more and submit your artwork.

About Zandra
Submit Your Artwork
Submit Your Artwork
About Zandra

Fifty Years of Fabulous

Dame Zandra Lindsey Rhodes is an English fashion and textile designer. Her early education in fashion set the foundation for a career in the industry creating textile prints. Rhodes has designed garments for Diana, Princess of Wales and numerous celebrities such as rock stars Freddie Mercury and Marc Bolan. Learn more at ZandraRhodes.com.

Selected works will be showcased in the “Make Alzheimer’s Visible” exhibition, inspiring engagement and advancing the mission to fight Alzheimer’s. Additionally, Dame Zandra Rhodes herself will create a special piece of artwork to be auctioned at the Cardinal Gala, with proceeds supporting Alzheimer’s research.

Learn more and submit your artwork.

Place Your Bid

Bid for Hope

Advance Alzheimer’s Research with Every Winning Offer

Our auction offers an exciting opportunity to bid on incredible items while directly contributing to the fight against Alzheimer’s disease.

Every winning bid helps fund groundbreaking research, drive advancements in treatment and prevention, and bring hope to millions of families affected by Alzheimer’s.

Together, we can turn your generosity into meaningful progress.

An Accelerated Timeline

There have been more breakthroughs in Alzheimer’s research and treatments in the past 10 years than in all previous years combined. Dedicated research and collaboration with volunteers and medical professionals have accelerated discoveries that promise to transform the future of Alzheimer’s disease. As we mark the next decade ahead at ATRI, we reflect on the strides made toward awareness and treatment of primary prevention. With continued support and innovation, the next decade will bring us closer to breakthroughs that will significantly alter the course of this disease, offering hope to millions affected worldwide.
Explore the Interactive Timeline

Our Partners

The last ten years of Alzheimer’s breakthroughs would not be possible without the incredible support of our partners.  Together, we’re driving progress toward primary prevention and making a lasting impact.  Interested in joining this vital mission?  Become a partner today!
Learn More

Latest News

Read the latest headlines from Alzheimer’s research at ATRI

News Item #3
With an Extended Title As Needed

Learn More

News Item #2
With an Extended Title As Needed

Learn More

News Item #1
With an Extended Title As Needed

Learn More
Read More Headlines »

Karen Bell

Dr. Karen Bell, Professor of Neurology at Columbia University Medical Center, in the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain and the GH Sergievsky Center, specializes in neurodegenerative cognitive disorders. As Director of the Education Core at Columbia’s Alzheimer’s Disease Research Center, she develops physician and community education programs. Dr. Bell is active in professional organizations, serves on multiple advisory boards, and mentors students through the Harlem Children Society.

Adam Boxer

Dr. Adam L. Boxer, Endowed Professor in Memory and Aging at the University of California, San Francisco, directs the Neurosciences Clinical Research Unit and the Alzheimer’s Disease and Frontotemporal Degeneration (FTD) Clinical Trials Program. He serves as the Principal Investigator of the Advancing Research and Treatment for FTLD (ARTFL) Rare Disease Clinical Research Consortium and has led major studies including the Four Repeat Tauopathy Neuroimaging Initiative (4RTNI).

Maria Carrillo

Dr. Maria Carrillo, Chief Science Officer of the Alzheimer’s Association, leads the world’s largest nonprofit research program for Alzheimer’s and dementia. She oversees global initiatives, including the Alzheimer’s Association International Conference (AAIC) and is a co-principal investigator for the Alzheimer’s Network for Treatment and Diagnostics, tracking outcomes of FDA-approved therapies. An internationally recognized expert, Dr. Carrillo has received numerous awards for advancing Alzheimer’s clinical trials and serves on prominent boards in the field.

Sandrine Andrieu

Dr. Sandrine Andrieu is a professor of public health and Chair of the Clinical Epidemiology and Public Health Department at Toulouse University Hospital. She leads the aging research team at the Center for Epidemiology and Research in Population Health (CERPOP) and has published over 300 works on aging and Alzheimer’s disease. Dr. Andrieu specializes in Alzheimer’s prevention, age-related functional prevention, and healthy aging. She is actively involved in major European studies and serves as the scientific committee president for France Alzheimer.

Suzanne Craft

Dr. Suzanne Craft is a Professor of Medicine at Wake Forest School of Medicine and is the Founding Director of the NIA-funded Alzheimer’s Disease Research Center. Her research focuses on metabolic disorders in Alzheimer’s development, leading innovative clinical trials on treatments such as intranasal insulin and dietary intervention. Craft is a recipient of the National Institute of Health MERIT Award and the Alzheimer’s Association Zenith Award. She has served on prestigious advisory groups, including the NIA Board of Scientific Counselors and the Alzheimer’s Clinical Trial Consortium (ACTC).

Jeffrey Cummings

Dr. Jeffrey L. Cummings, a renowned Alzheimer’s researcher and clinical trial leader, is a research professor at the University of Nevada, Las Vegas Department of Brain Health. Previously, he founded the Cleveland Clinic Lou Ruvo Center for Brain Health and directed Alzheimer’s research centers at the University of California, Los Angeles. Ranked among the top Alzheimer’s scientists globally, Dr. Cummings focuses on embracing clinical trials, developing therapies for brain diseases, and the interface of neuroscience and society. He has received numerous awards, including the Alzheimer’s Association’s Bengt Winblad Lifetime Achievement Award and the Society for Behavioral and Cognitive Neurology’s Lifetime Achievement Award. He also serves as Director of the National Institute of General Medical Sciences-funded Center for Neurodegeneration and Translational Neuroscience.

Bonnie Davis

Takeshi Iwatsubo

Michael S. Rafii

Michael S. Rafii, MD, PhD, is a Professor of Clinical Neurology at the Keck School of Medicine and Medical Director of the Alzheimer’s Therapeutic Research Institute (ATRI). His research focuses on developing treatments for Alzheimer’s disease, including its genetic form in individuals with Down syndrome. He is Principal Investigator for the NIH-funded Alzheimer’s Clinical Trials Consortium – Down Syndrome (ACTC-DS) and serves in leadership roles at ATRI and the Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Robert Rissman

Dr. Robert Rissman is a Professor of Physiology and Neuroscience, the W.M. Keck Endowed Professor in Medicine, and the founding Director of the Neuroscience Translational Research Division (NTRD) at ATRI. He leads the ATRI Biomarker Laboratory and Biorepository and serves as the ACTC Biorepository Unit Lead. His research focuses on biomarker discovery in Alzheimer’s Disease (AD), aiming to understand how treatment parameters may impact these biomarkers.

Ronald Petersen

Dr. Ronald C. Petersen, M.D., Ph.D., is a leading researcher in cognitive aging, focusing on conditions such as Alzheimer’s, frontotemporal lobar degeneration, and Lewy body dementia. He directs both the Mayo Clinic Alzheimer’s Disease Research Center and the Mayo Clinic Study of Aging, where his team examines aging individuals over time using neuroimaging and biomarkers to understand cognitive changes and neurodegenerative disorders.

Phyllis Barkman Ferrell

Phyllis Ferrell is a global leader in brain health and longevity innovation. After three decades at Eli Lilly & Company, where she advanced Alzheimer’s therapeutics and diagnostics, she now advises organizations to transform health systems worldwide. As Chief Impact Officer for StartUp Health Alzheimer’s Moonshot, she champions innovation in Alzheimer’s care. Ferrell also supports global initiatives like the Davos Alzheimer’s Collaborative to prepare healthcare systems for aging populations. She holds leadership roles in numerous health and advocacy organizations and is passionate about improving brain health to support future generations.

Lawrence Honig

Dr. Lawrence S. Honig, Professor of Neurology at Columbia University Irving Medical Center, is a renowned expert in neurodegenerative diseases, including Alzheimer’s disease, Lewy Body Dementia, Frontotemporal Degeneration, and Progressive Supranuclear Palsy. He directs the New York State Center of Excellence for Alzheimer’s Disease and co-directs the Lewy Body Disease Research Center of Excellence and the Progressive Supranuclear Palsy Center of Care.  With board certifications in Behavioral Neurology, Neuropsychiatry, and Geriatric Neurology, Dr. Honig combines clinical expertise with groundbreaking research. He serves as a principal investigator for observational studies and clinical drug trials focused on advancing treatments for neurodegenerative conditions. A member of Columbia’s faculty since 2000, he has made significant contributions to understanding and addressing disorders of nervous system aging and degeneration.

Nancy Lynn Keach

Nancy Lynn Keach, Senior Vice President of Strategic Partnerships at BrightFocus Foundation, facilitates partnerships to advance research and awareness for Alzheimer’s, Macular Degeneration, and Glaucoma. She has worked on the acclaimed film Glen Campbell…I’ll Be Me and is Executive Producer for Turning Point, a documentary on Alzheimer’s research. Formerly Executive Director and Chief Operating Officer at the Alzheimer’s Drug Discovery Foundation, Lynn has also held leadership roles at the Arnold P. Gold Foundation for Humanism in Medicine and the American Museum of Natural History in New York. She is a founding member of WomenAgainstAlzheimer’s.

Doris Molina-Henry

Doris Molina-Henry is an Assistant Professor at the USC Keck School of Medicine Alzheimer’s Therapeutic Research Institute. She is part of the leadership of the Alzheimer’s Therapeutic Research Institute in San Diego. Her work is focused on the science of recruitment and retention of diverse participants into clinical trials. Currently, she works on evaluating strategies that promote participation of cognitively unimpaired, at-risk, diverse adults into studies that aim to help prevent the symptoms of Alzheimer’s well before they begin.

Laurie Ryan

Dr. Laurie Ryan is Chief of the Clinical Interventions and Diagnostics Branch Division of Neuroscience at the National Institute on Aging, overseeing clinical research programs focused on Alzheimer’s disease and related dementias. With a background in clinical neuropsychology, she previously worked at the Defense and Veterans Brain Injury Center (DVBIC) and became the Assistant Director for Research. Dr. Ryan joined the NIA in 2005 and has played a key role in Alzheimer’s clinical trials, eventually being promoted to the branch chief position in 2013.

Marwan Sabbagh

Dr. Marwan Sabbagh, M.D., is a behavioral neurologist and the Moreno Family Chair for Alzheimer’s Research at the Barrow Neurological Institute. A specialist in Alzheimer’s diagnosis and treatment, he also serves as the Vice Chair of Research at the Institute’s Department of Neurology. Dr. Sabbagh has led numerous national Alzheimer’s prevention and treatment trials and serves as editor-in-chief of Neurology and Therapy. He has authored several books and contributed to numerous scientific articles.

Reisa A. Sperling

Dr. Reisa Sperling is a neurologist at Harvard Medical School and Director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital. She leads studies on Alzheimer’s detection, including the A4 study, and led the NIA-Alzheimer’s Association workgroup to develop guidelines for “Preclinical Alzheimer’s disease.” Dr. Sperling was awarded the American Academy of Neurology Potamkin Prize and recognized as one of the 2017 Most Disruptive Women in Healthcare.

Arthur W. Toga

Dr. Toga focuses on neuroimaging algorithms, developing new visualization techniques and statistical measurements. His research includes creating 3D digital neuroanatomic atlases for precise localization and multisubject comparisons. His work involves local deformation methods to equate brain data from various subjects and modalities and the development of electronic databases for archiving and sharing brain data.

Michael Weiner

Dr. Michael Weiner is a Professor Emeritus at the University of California, San Francisco and the Principal Investigator of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the largest observational study on Alzheimer’s disease. His research focuses on using MRI, PET, and biomarkers for diagnosing neurodegenerative diseases, particularly Alzheimer’s. He has pioneered the use of magnetic resonance spectroscopy (MRS) in clinical applications and leads several initiatives to identify and monitor Alzheimer’s disease progression.

Heather M. Snyder

Dr. Heather M. Snyder, Ph.D., is Senior Vice President for Medical & Scientific Relations at the Alzheimer’s Association. She oversees the association’s global funding initiatives, including the International Research Grant Program. Dr. Snyder is also involved in strategic studies like the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER). As a leading expert in the field, Snyder has been prominently featured in tv, print, and online mediums including The New York Times, The Washington Post and The Wall Street Journal. 

Bruno Vellas

Dr. Bruno Vellas is the founder of Institut Hospitalier Universitaire (IHU) HealthAge in Toulouse. Vellas chairs the Gérontopôle & Department of Geriatric Internal Medicine, Alzheimer’s Disease Research and Clinical Center at the Toulouse University Hospital. He has been pivotal in the creation of major initiatives like European Alzheimer’s Disease Consortium (EADC), Clinical Trials on Alzheimer’s Disease (CTAD), and The Journal of Prevention of Alzheimer’s Disease (JPAD). He has authored over 500 publications, holds multiple leadership roles in international scientific advisory boards, and was elected to the French National Academy of Medicine in 2016.

Carrie Aisen

Mindy Aisen

Josephine Chen-Habibi

Lisa Bilotti

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec hendrerit interdum metus, ac rutrum ex dapibus vitae. Aenean lacinia ex felis, id pellentesque ante aliquet a. Nunc elementum sapien ultricies…

Cini Gannon-Robb

Sally Oxley

Candace Leeds-Sears

Shelley Moore

Zandra Rhodes

Pamela Spain

Caroline Wohl

Hanaa Zahran